These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24598177)

  • 21. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder.
    Pliszka SR
    Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. With the recent Food and Drug Administration (FDA) Advisory Committee's recommendation to put a black box warning on stimulants, the government has joined the media in raising alarm about the medical treatment of attention-deficit disorder.
    Hackford R
    J Dev Behav Pediatr; 2006 Apr; 27(2):179. PubMed ID: 16682886
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADHD, Ritalin, and big brother.
    Miller AL
    Altern Med Rev; 2000 Oct; 5(5):401. PubMed ID: 11056410
    [No Abstract]   [Full Text] [Related]  

  • 26. Attention-deficit-hyperactivity disorder.
    Diller LH
    N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
    [No Abstract]   [Full Text] [Related]  

  • 27. The latest drugs on the FDA's radar.
    Waldron T
    Behav Healthc; 2006 Jun; 26(6):34-5. PubMed ID: 16833213
    [No Abstract]   [Full Text] [Related]  

  • 28. Dexmethylphenidate for attention deficit hyperactivity disorder.
    Coury D
    Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in emotions related to medication used to treat ADHD. Part I: literature review.
    Manos MJ; Brams M; Childress AC; Findling RL; López FA; Jensen PS
    J Atten Disord; 2011 Feb; 15(2):101-12. PubMed ID: 20876887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

  • 32. The neurological basis of attention deficit hyperactivity disorder.
    Ballard S; Bolan M; Burton M; Snyder S; Pasterczyk-Seabolt C; Martin D
    Adolescence; 1997; 32(128):855-62. PubMed ID: 9426808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using stimulants in children with ADHD.
    Waschbusch DA; Pelham WE
    Science; 2004 Nov; 306(5701):1473. PubMed ID: 15567835
    [No Abstract]   [Full Text] [Related]  

  • 34. Stimulants, ADHD, and the heart.
    Ganiats TG
    Am Fam Physician; 2009 May; 79(10):846, 851. PubMed ID: 19496384
    [No Abstract]   [Full Text] [Related]  

  • 35. Methylphenidate: its pharmacology and uses.
    Challman TD; Lipsky JJ
    Mayo Clin Proc; 2000 Jul; 75(7):711-21. PubMed ID: 10907387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 37. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
    Marsden CA
    Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 39. ADHD drugs and cardiovascular risk.
    Wojnowski L
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
    [No Abstract]   [Full Text] [Related]  

  • 40. The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology.
    March JS
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):427-30. PubMed ID: 21515189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.